Tissue Regenix Group plc (LON:TRX – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 60.55 ($0.75) and traded as low as GBX 57 ($0.70). Tissue Regenix Group shares last traded at GBX 57 ($0.70), with a volume of 18,582 shares traded.
Tissue Regenix Group Stock Down 2.6 %
The firm has a market cap of £40.60 million, a PE ratio of -5,700.00 and a beta of 1.61. The company has a quick ratio of 2.36, a current ratio of 3.74 and a debt-to-equity ratio of 35.69. The business has a 50-day moving average price of GBX 58.80 and a two-hundred day moving average price of GBX 60.53.
About Tissue Regenix Group
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Read More
- Five stocks we like better than Tissue Regenix Group
- Best Aerospace Stocks Investing
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- How to Calculate Return on Investment (ROI)
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- What is Forex and How Does it Work?
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
